Tools

LEADER 03838cam 22006014a 4500

001 ssj0000220586;

003 WaSeSS;

005 20250212121027.0;

006 m d ;

007 cr n ;

008 060922s2007 enka sb 001 0 eng d;

010 a| 2006031632;

015 a| GBA7242152| bnb;

016 7 a| 1012882182| DNLM;

016 7 a| 0137043992| Uk;

020 a| 0521874904 (hardback);

020 a| 9780521874908 (hardback);

035 a| (WaSeSS)ssj0000220586;

042 a| pcc;

049 a| EREEa| NEHH;

050 00 a| RA401.A1b| P43 2007;

082 00 a| 338.4/761512| 22;

245 00 a| Pharmaceutical innovationh| [electronic resource] :b| incentives, competition, and cost-benefit analysis in international perspective /c| edited by Frank A. Sloan, Chee-Ruey Hsieh.;

260 a| Cambridge ;a| New York :b| Cambridge University Press,;

300 a| xiv, 331 p. :b| ill. ;c| 24 cm.;

504 a| Includes bibliographical references (p. 293-317) and index.;

505 0 a| Introduction / Frank A. Sloan and Chee-Ruey Hsieh -- The pharmaceutical sector in health care / Uwe E. Reinhardt -- The economics of research and development in the pharmaceutical industry / William S. Comanor -- Drugs for neglected diseases: new incentives for innovation / Aidan Hollis -- When patents fail: finding new drugs for the developing world / Stephen M. Maurer -- Implementing a public subsidy for vaccines / Frank A. Sloan and Charles E. Eesley -- Ensuring the future supply of vaccines: is a national vaccine authority the answer? / Frank R. Lichtenberg -- Competition between generic and branded drugs / Henry Grabowski -- The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned? / Ernst R. Berndt -- Measures of costs and benefits for drugs in cost-effectiveness analysis / Mark V. Pauly -- Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience / Michael Drummond -- Pharmaceutical spending and health outcomes / Pierre-Yves Cremieux ... [et al.] -- Pharmaceutical innovation and health outcomes: empirical evidence from Taiwan / Chee-Ruey Hsieh ... [et al.] -- Conclusions and policy implications / Frank A. Sloan and Chee-Ruey Hsieh.;

506 a| Available only to authorized users.;

538 a| Mode of access: World Wide Web;

650 0 a| Pharmaceutical policy.=| ^A7334;

650 0 a| Pharmaceutical industry.=| ^A3655;

650 0 a| Drug developmentx| Technological innovationsx| Economic aspects.=| ^A443888;

650 12 a| Drug Industryx| economics.=| ^A1004813;

650 22 a| Cost-Benefit Analysis.=| ^A919295;

650 22 a| Economic Competition.=| ^A930238;

650 22 a| Health Policy.=| ^A920924;

650 22 a| Pharmaceutical Preparationsx| economics.=| ^A948134;

650 22 a| Vaccinesx| economics.=| ^A1204322;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Sloan, Frank A.=| ^A5977;

700 1 a| Hsieh, Chee-Ruey.=| ^A913334;

856 40 z| Full text available from eBooks on EBSCOhostu| https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=198870&scope=site&custid=s5822723&authtype=ip,shib;

947 a| (OCoLC)ocm71798106;

947 a| (OCoLC)71798106;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 4225536;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4225536-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 1/2/2016x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4225536-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 1/2/2016x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4225536-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 1/2/2016x| EBOOKz| JERESOURCE;

Pharmaceutical innovation incentives, competition, and cost-benefit analysis in international perspective / edited by Frank A. Sloan, Chee-Ruey Hsieh.

Other author	Sloan, Frank A.
Other author	Hsieh, Chee-Ruey.
Format	Electronic
Publication Info	Cambridge ; New York : Cambridge University Press,
Description	xiv, 331 p. : ill. ; 24 cm.
Supplemental Content	Full text available from eBooks on EBSCOhost
Subjects	Pharmaceutical policy. Pharmaceutical industry. Drug development--Technological innovations. --Economic aspects. Drug Industry--economics. Cost-Benefit Analysis. Economic Competition. Health Policy. Pharmaceutical Preparations--economics. Vaccines--economics.

Contents	Introduction / Frank A. Sloan and Chee-Ruey Hsieh -- The pharmaceutical sector in health care / Uwe E. Reinhardt -- The economics of research and development in the pharmaceutical industry / William S. Comanor -- Drugs for neglected diseases: new incentives for innovation / Aidan Hollis -- When patents fail: finding new drugs for the developing world / Stephen M. Maurer -- Implementing a public subsidy for vaccines / Frank A. Sloan and Charles E. Eesley -- Ensuring the future supply of vaccines: is a national vaccine authority the answer? / Frank R. Lichtenberg -- Competition between generic and branded drugs / Henry Grabowski -- The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned? / Ernst R. Berndt -- Measures of costs and benefits for drugs in cost-effectiveness analysis / Mark V. Pauly -- Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience / Michael Drummond -- Pharmaceutical spending and health outcomes / Pierre-Yves Cremieux ... [et al.] -- Pharmaceutical innovation and health outcomes: empirical evidence from Taiwan / Chee-Ruey Hsieh ... [et al.] -- Conclusions and policy implications / Frank A. Sloan and Chee-Ruey Hsieh.
Bibliography note	Includes bibliographical references (p. 293-317) and index.
Access restriction	Available only to authorized users.
Technical details	Mode of access: World Wide Web
Genre/form	Electronic books.
LCCN	2006031632
ISBN	0521874904 (hardback)
ISBN	9780521874908 (hardback)

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Pharmaceutical innovation incentives, competition, and cost-benefit analysis in international perspective / edited by Frank A. Sloan, Chee-Ruey Hsieh.

Click here for more information about this title

Availability